The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Open accessAbstract
SUMMARY: Treatment of infectious diseases becomes more challenging with each passing year. This is especially true for infections caused by the opportunistic pathogen Pseudomonas aeruginosa, with its ability to rapidly develop resistance to multiple classes of antibiotics. Although the import of resistance mechanisms on mobile genetic elements is always a concern, the most difficult challenge we face with P. aeruginosa is its ability to rapidly develop resistance during the course of treating an infection. The chromosomally encoded AmpC cephalosporinase, the outer membrane porin OprD, and the multidrug efflux pumps are particularly relevant to this therapeutic challenge. The discussion presented in this review highlights the clinical significance of these chromosomally encoded resistance mechanisms, as well as the complex mechanisms/pathways by which P. aeruginosa regulates their expression. Although a great deal of knowledge has been gained toward understanding the regulation of AmpC, OprD, and efflux pumps in P. aeruginosa, it is clear that we have much to learn about how this resourceful pathogen coregulates different resistance mechanisms to overcome the antibacterial challenges it faces.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Nosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404 · cited 1×
“aeruginosa as the second most common cause of nosocomial pneumonia, health care-associated pneumonia, and ventilator-associated pneumonia (64, 106) and the leading cause of pneumonia among pediatric patients in the intensive care unit (ICU) (214).”
BackgroundAn overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286
Growth of the Stress-Bearing and Shape-Maintaining Murein Sacculus of Escherichia coli
Höltje, J.-V. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.181-203.1998 · Cited by 1,129
Multidrug efflux pumps of gram-negative bacteria
Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.20.5853-5859.1996 · Cited by 1,082
Epidemiology and Outcomes of Health-care–Associated Pneumonia
Kollef, M. H., Shorr, A., Tabak, Y. P., Gupta, V., Liu, L. Z., & Johannes, R. S. (2005) · Chest · doi:10.1378/chest.128.6.3854 · Cited by 948
(1999) · American Journal of Infection Control · doi:10.1016/s0196-6553(99)70031-3 · Cited by 901
Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme
Park, C. H., Robicsek, A., Jacoby, G. A., Sahm, D., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00915-06 · Cited by 757
Cell-to-Cell Signaling and Pseudomonas aeruginosa Infections
Van Delden, C., & Iglewski, B. H. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0404.980405 · Cited by 745
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 684
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa
Li, X. Z., Nikaido, H., & Poole, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1948 · Cited by 643
Transferable imipenem resistance in Pseudomonas aeruginosa
Watanabe, M., Iyobe, S., Inoue, M., & Mitsuhashi, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.147 · Cited by 619
Multidrug-Resistant Pseudomonas aeruginosa : Risk Factors and Clinical Impact
Aloush, V., Navon-Venezia, S., Seigman-Igra, Y., Cabili, S., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.43-48.2006 · Cited by 617
Resistance Mechanisms in Pseudomonas aeruginosa and Other Nonfermentative Gram‐Negative Bacteria
Hancock, R. E. W. (1998) · Clinical Infectious Diseases · doi:10.1086/514909 · Cited by 583
Nosocomial Infections in Pediatric Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, T. N. N. I. S. (1999) · Pediatrics · doi:10.1542/peds.103.4.e39 · Cited by 572
qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States
Robicsek, A., Strahilevitz, J., Sahm, D. F., Jacoby, G. A., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01647-05 · Cited by 569
Ko¨hler, T., Michéa‐Hamzehpour, M., Henze, U., Gotoh, N., Kocjancic Curty, L., & Pechère, J. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2281594.x · Cited by 549
Micek, S. T., Lloyd, A. E., Ritchie, D. J., Reichley, R. M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1306-1311.2005 · Cited by 526
The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
Livermore, D. M., & Woodford, N. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.07.008 · Cited by 510
Aminoglycoside Resistance in Pseudomonas aeruginosa
Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.479-487.2005 · Cited by 470
Outer membrane barrier as a mechanism of antimicrobial resistance
Nikaido, H. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.11.1831 · Cited by 462
Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T., Neshat, S., Yamagishi, J., Li, X., & Nishino, T. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.281397.x · Cited by 443
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409
Van Bambeke, F., Balzi, E., & Tulkens, P. M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00291-4 · Cited by 404
Jacobs, C., Huang, L. J., Bartowsky, E., Normark, S., & Park, J. T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06792.x · Cited by 400
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria
Poole, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2233-2241.2000 · Cited by 371
Health and Economic Outcomes of Antibiotic Resistance in Pseudomonas aeruginosa
Carmeli, Y., Troillet, N., Karchmer, A. W., & Samore, M. H. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1127 · Cited by 363
Perron, K., Caille, O., Rossier, C., van Delden, C., Dumas, J.-L., & Köhler, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312080200 · Cited by 358
Karlowsky, J. A., Draghi, D. C., Jones, M. E., Thornsberry, C., Friedland, I. R., & Sahm, D. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1681-1688.2003 · Cited by 351
Galimand, M., Courvalin, P., & Lambert, T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2565-2571.2003 · Cited by 350
Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12
Yoshimura, F., & Nikaido, H. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.1.84 · Cited by 343
Jacobs, C., Frère, J.-M., & Normark, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81928-5 · Cited by 331
Toleman, M. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf210 · Cited by 327
Poole, K., Tetro, K., Zhao, Q., Neshat, S., Heinrichs, D. E., & Bianco, N. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2021 · Cited by 324
Carbapenemases: a problem in waiting?
Livermore, D. M., & Woodford, N. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00128-4 · Cited by 323
Function of Pseudomonas Porins in Uptake and Efflux
Hancock, R. E. W., & Brinkman, F. S. L. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160310 · Cited by 319
Köhler, T., Epp, S. F., Curty, L. K., & Pechère, J.-C. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.20.6300-6305.1999 · Cited by 302
Mercuri, E., Rutherford, M., Cowan, F., Pennock, J., Counsell, S., Papadimitriou, M., Azzopardi, D., Bydder, G., & Dubowitz, L. (1999) · Pediatrics · doi:10.1542/peds.103.1.39 · Cited by 298
De Kievit, T. R., Parkins, M. D., Gillis, R. J., Srikumar, R., Ceri, H., Poole, K., Iglewski, B. H., & Storey, D. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1761-1770.2001 · Cited by 294
Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-06 · Cited by 293
Epidemiology of Infections Due to Pseudomonas aeruginosa
Morrison, A. J., & Wenzel, R. P. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_3.s627 · Cited by 291
Trias, J., & Nikaido, H. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.52 · Cited by 291
Livermore, D. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.2046 · Cited by 288
Obritsch, M. D., Fish, D. N., MacLaren, R., & Jung, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4606-4610.2004 · Cited by 288
Schweizer, H. P. (2003) · PubMed · Cited by 287
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Moya, B., Dötsch, A., Juan, C., Blázquez, J., Zamorano, L., Haussler, S., & Oliver, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000353 · Cited by 287
Köhler, T., van Delden, C., Curty, L. K., Hamzehpour, M. M., & Pechere, J.-C. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5213-5222.2001 · Cited by 287
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.972-978.2003 · Cited by 286 · cited 1×
“Several mutations have been described for nfxB from laboratory strains and clinical isolates, such as base substitutions, deletions, and interruption with an IS element (37, 90, 203).”
BackgroundContribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2242-2246.2000 · Cited by 279
Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C., & Plésiat, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1797-1802.2004 · Cited by 277
Emergence of Resistance to Imipenem During Therapy for Pseudomonas aeruginosa Infections
Quinn, J. P., Dudek, E. J., DiVincenzo, C. A., Lucks, D. A., & Lerner, S. A. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.2.289 · Cited by 276
Expression in Escherichia coli of a New Multidrug Efflux Pump, MexXY, from Pseudomonas aeruginosa
Mine, T., Morita, Y., Kataoka, A., Mizushima, T., & Tsuchiya, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.415 · Cited by 274
Multidrug Efflux in Pseudomonas aeruginosa Components, Mechanisms and Clinical Significance
Poole, K., & Srikumar, R. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013395605 · Cited by 271
Jones, M. E., Draghi, D. C., Thornsberry, C., Karlowsky, J. A., Sahm, D. F., & Wenzel, R. P. (2004) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-3-14 · Cited by 269
Köhler, T., Michea-Hamzehpour, M., Epp, S. F., & Pechere, J.-C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.424 · Cited by 268
Evolutionary origins of multidrug and drug‐specific efflux pumps in bacteria
Saier, M. H., Paulsen, I. T., Marek, K. S., Pao, S. S., Ronald, A. S., & Nikaido, H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.03.265 · Cited by 263
Castanheira, M., Toleman, M. A., Jones, R. N., Schmidt, F. J., & Walsh, T. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4654-4661.2004 · Cited by 261
Predominant pathogens found in the European prevalence of infection in intensive care study
Spencer, R. C. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01695658 · Cited by 261
Changes of microbial flora and wound colonization in burned patients
Erol, S., Altoparlak, U., Akcay, M. N., Celebi, F., & Parlak, M. (2004) · Burns · doi:10.1016/j.burns.2003.12.013 · Cited by 254
Naas, T., & Nordmann, P. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230112185101 · Cited by 250
Recycling of murein by Escherichia coli
Goodell, E. W. (1985) · Journal of Bacteriology · doi:10.1128/jb.163.1.305-310.1985 · Cited by 245
Gales, A. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg416 · Cited by 242
Westbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., & Stover, C. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2975 · Cited by 242
Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa
Yokoyama, K., Doi, Y., Yamane, K., Kurokawa, H., Shibata, N., Shibayama, K., Yagi, T., Kato, H., & Arakawa, Y. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14959-8 · Cited by 242
Jalal, S., Ciofu, O., Høiby, N., Gotoh, N., & Wretlind, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.710-712.2000 · Cited by 236
Aendekerk, S., Diggle, S. P., Song, Z., Høiby, N., Cornelis, P., Williams, P., & Cámara, M. (2005) · Microbiology · doi:10.1099/mic.0.27631-0 · Cited by 235
Weldhagen, G. F., Poirel, L., & Nordmann, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2385-2392.2003 · Cited by 231
Chuanchuen, R., Narasaki, C. T., & Schweizer, H. P. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.18.5036-5044.2002 · Cited by 228
Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa
Masuda, N., Sakagawa, E., & Ohya, S. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.645 · Cited by 226
Philippon, L. N., Naas, T., Bouthors, A. T., Barakett, V, & Nordmann, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2188 · Cited by 215
Ochs, M. M., McCusker, M. P., Bains, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1085 · Cited by 214
Aendekerk, S., Ghysels, B., Cornelis, P., & Baysse, C. (2002) · Microbiology · doi:10.1099/00221287-148-8-2371 · Cited by 212
Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01410-08 · Cited by 211
Trias, J., & Nikaido, H. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55452-1 · Cited by 210
Galimand, M., Sabtcheva, S., Courvalin, P., & Lambert, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2949-2953.2005 · Cited by 209
Prevalence of Plasmid-Mediated Quinolone Resistance
Jacoby, G. A., Chow, N., & Waites, K. B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.559-562.2003 · Cited by 209
(1998) · American Journal of Infection Control · doi:10.1016/s0196-6553(98)70026-4 · Cited by 209
Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact
Gasink, L. B., Fishman, N. O., Weiner, M. G., Nachamkin, I., Bilker, W. B., & Lautenbach, E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.029 · Cited by 206
Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates
Pai, H., Kim, J.-W., Kim, J., Lee, J. H., Choe, K. W., & Gotoh, N. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.480-484.2001 · Cited by 205
Girlich, D., Naas, T., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2043-2048.2004 · Cited by 201
Jacobs, C., Joris, B., Jamin, M., Klarsov, K., van Beeumen, J., Mengin‐Lecreulx, D., van Heijenoort, J., Park, J. T., Normark, S., & Frère, J. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02268.x · Cited by 199
Vallet-Gély, I., Diggle, S. P., Stacey, R. E., Cámara, M., Ventre, I., Lory, S., Lazdunski, A. M., Williams, P. M., & Filloux, A. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.9.2880-2890.2004 · Cited by 198
Outer Membranes and Efflux: The Path to Multidrug Resistance in Gram- Negative Bacteria
Poole, K. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378454 · Cited by 198
Poole, K., Heinrichs, D. E., & Neshat, S. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb00925.x · Cited by 196
Regulation of Inducible AmpC Beta-Lactamase Expression Among Enterobacteriaceae
Hanson, N. D., & Sanders, C. C. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230112191507 · Cited by 194
Self-citationLandman, D., Bratu, S., Kochar, S., Panwar, M., Trehan, M., Doymaz, M., & Quale, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm129 · Cited by 192
Maseda, H., Sawada, I., Saito, K., Uchiyama, H., Nakae, T., & Nomura, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1320-1328.2004 · Cited by 192
H-NS family members function coordinately in an opportunistic pathogen
Castang, S., McManus, H. R., Turner, K. H., & Dove, S. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808215105 · Cited by 188
Doi, Y., Yokoyama, K., Yamane, K., Wachino, J.-I., Shibata, N., Yagi, T., Shibayama, K., Kato, H., & Arakawa, Y. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.491-496.2004 · Cited by 187
The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism
Chen, H., Hu, J., Chen, P. R., Lan, L., Li, Z., Hicks, L. M., Dinner, A. R., & He, C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803391105 · Cited by 186
Srikumar, R., Kon, T., Gotoh, N., & Poole, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.65 · Cited by 184
Naas, T., & Nordmann, P. (1999) · PubMed · Cited by 183
Molecular Basis of Azithromycin-Resistant Pseudomonas aeruginosa Biofilms
Gillis, R. J., White, K. G., Choi, K.-H., Wagner, V. E., Schweizer, H. P., & Iglewski, B. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3858-3867.2005 · Cited by 183
Regulatory components in Citrobacter freundii ampC beta-lactamase induction.
Lindberg, F., Westman, L., & Normark, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.14.4620 · Cited by 182
Honoré, N., Nicolas, M. H., & Cole, S. T. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04704.x · Cited by 180
Bert, F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf069 · Cited by 180
Sobel, M. L., McKay, G. A., & Poole, K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3202-3207.2003 · Cited by 179
Inducible -Lactamases: Clinical and Epidemiologic Implications for Use of Newer Cephalosporins
Sanders, W. E., & Sanders, C. C. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.830 · Cited by 176
Sobel, M. L., Neshat, S., & Poole, K. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.4.1246-1253.2005 · Cited by 176
Juan, C., Maciá, M. D., Gutiérrez, O., Vidal, C., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4733-4738.2005 · Cited by 175
Caille, O., Rossier, C., & Perron, K. (2007) · Journal of Bacteriology · doi:10.1128/jb.00095-07 · Cited by 174
BONTEN, M. J. M., BERGMANS, D. C. J. J., SPEIJER, H., & STOBBERINGH, E. E. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.4.9809031 · Cited by 170
Novel Genetic Determinants of Low-Level Aminoglycoside Resistance in Pseudomonas aeruginosa
Schurek, K. N., Marr, A. K., Taylor, P. K., Wiegand, I., Semenec, L., Khaira, B. K., & Hancock, R. E. W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00507-08 · Cited by 169
Type I -Lactamases of Gram-Negative Bacteria: Interactions with -Lactam Antibiotics
Sanders, C. C., & SandersJr, W. E. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.5.792 · Cited by 167
Fraud, S., Campigotto, A. J., Chen, Z., & Poole, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01072-08 · Cited by 166
Jeannot, K., Sobel, M. L., El Garch, F., Poole, K., & Plésiat, P. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.15.5341-5346.2005 · Cited by 165
Mushtaq, S., Ge, Y., & Livermore, D. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3086-3092.2004 · Cited by 164
Breidenstein, E. B. M., Khaira, B. K., Wiegand, I., Overhage, J., & Hancock, R. E. W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00222-08 · Cited by 160
Srikumar, R., Paul, C. J., & Poole, K. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.5.1410-1414.2000 · Cited by 160
Cao, L., Srikumar, R., & Poole, K. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04210.x · Cited by 159
Morita, Y., Sobel, M. L., & Poole, K. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.5.1847-1855.2006 · Cited by 158
Substrate Specificity of the AmpG Permease Required for Recycling of Cell Wall Anhydro-Muropeptides
Cheng, Q., & Park, J. T. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.23.6434-6436.2002 · Cited by 156
Köhler, T., Kok, M., Michea-Hamzehpour, M., Plésiat, P., Gotoh, N., Nishino, T., Curty, L. K., & Pechère, J. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2288 · Cited by 154
Dötsch, A., Becker, T., Pommerenke, C., Magnowska, Z., Jänsch, L., & Häußler, S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-09 · Cited by 153
Mima, T., Joshi, S. M., Escalada, M. G., & Schweizer, H. P. (2007) · Journal of Bacteriology · doi:10.1128/jb.00850-07 · Cited by 153
Evans, K., Adewoye, L. O., & Poole, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.3.807-812.2001 · Cited by 152
A new member of the tripartite multidrug efflux pumps,MexVW-OprM, in Pseudomonas aeruginosa
Li, Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg390 · Cited by 151
Bisbe, J., Gatell, J. M., Puig, J. J., Mallolas, J., Martínez, J. A., de Anta, M. T. J., & Soriano, E. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.3.629 · Cited by 147
Lindberg, F. P., Lindquist, S., & Normark, S. J. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.5.1923-1928.1987 · Cited by 147
Maseda, H., Saito, K., Nakajima, A., & Nakae, T. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09367.x · Cited by 142
Amin, N. M. E., Giske, C. G., Jalal, S., KEIJSER, B., Kronvall, G., & Wretlind, B. (2005) · Apmis · doi:10.1111/j.1600-0463.2005.apm1130306.x · Cited by 142
Vogne, C., Aires, J., Bailly, C., Hocquet, D., & Plésiat, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1676-1680.2004 · Cited by 141
Mechanisms of Quinolone Resistance in Clinical Strains of Pseudomonas aeruginosa
Jalal, S., & Wretlind, B. (1998) · Microbial Drug Resistance · doi:10.1089/mdr.1998.4.257 · Cited by 139
Lodge, J., Minchin, S., Piddock, L. J. V., & Busby, S. J. W. (1990) · Biochemical Journal · doi:10.1042/bj2720627 · Cited by 138
Sobel, M. L., Hocquet, D., Cao, L., Plésiat, P., & Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1782-1786.2005 · Cited by 138
Cefepime: the next generation?
Sanders, C. C. (1993) · PubMed · Cited by 137
Hocquet, D., Nordmann, P., Garch, F. E., Cabanne, L., & Plésiat, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1347-1351.2006 · Cited by 136
Jeannot, K., Elsen, S., Köhler, T., Attree, I., van Delden, C., & Plésiat, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01107-07 · Cited by 136
Nordmann, P., & Naas, T. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.104 · Cited by 134
Type II Topoisomerase Mutations in Ciprofloxacin-Resistant Strains of Pseudomonas aeruginosa
Mouneimné, H., Robert, J., Jarlier, V., & Cambau, E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.62 · Cited by 134
Thuong, M., Arvaniti, K., Ruimy, R., Salmonière, P. D. L., Scanvic, A., Lucet, J. C., & Regnier, B. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1370 · Cited by 128
The negative regulator of β-lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase
Höltje, J.-V., Kopp, U., Ursinus, A., et al. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07159.x · Cited by 128
Palma, M., Zurita, J., Ferreras, J. A., Worgall, S., Larone, D. H., Shi, L., Campagne, F., & Quadri, L. E. N. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.2958-2966.2005 · Cited by 127
Li, X.-Z. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.6.885 · Cited by 124
Livermore, D. M., & Yang, Y.-J. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.4.775 · Cited by 122
Flamm, R. K., Weaver, M. K., Thornsberry, C., Jones, M. E., Karlowsky, J. A., & Sahm, D. F. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2431-2436.2004 · Cited by 122
MexZ-mediated regulation of multidrug efflux pump expression in by binding on the intergenic DNA
MATSUO, Y., EDA, S., Gotoh, N., Yoshihara, E., & Nakae, T. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.07.010 · Cited by 122
Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates
Pirnay, J., Vos, D. D., Mossialos, D., Vanderkelen, A., Cornélis, P., & Zizi, M. (2002) · Environmental Microbiology · doi:10.1046/j.1462-2920.2002.00281.x · Cited by 122
Bagge, N., Ciofu, O., Hentzer, M., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3406-3411.2002 · Cited by 121
Srikumar, R., Li, X., & Poole, K. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.24.7875-7881.1997 · Cited by 121
AmpG, a signal transducer in chromosomal β‐lactamase induction
Lindquist, S., Weston-Hafer, K. A., Schmidt, H., Pul, C., Korfmann, G., Erickson, J., Sanders, C., MARTIN, H. H., & Normark, S. J. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01731.x · Cited by 116
β-Lactamase Inhibitors Are Substrates for the Multidrug Efflux Pumps of Pseudomonas aeruginosa
Li, X.-Z., Zhang, L., Srikumar, R., & Poole, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.399 · Cited by 114
Masuda, N., Gotoh, N., Ishii, C., Sakagawa, E., Ohya, S., & Nishino, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.400 · Cited by 114
Gribble, M. J., CHOW, A. W. C., Naiman, S. C., et al. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.3.388 · Cited by 113
-Lactamases of Gram-Negative Bacteria: New Challenges for New Drugs
Sanders, C. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.5.1089 · Cited by 112
Oh, H., Stenhoff, J., Jalal, S., & Wretlind, B. (2003) · Microbial Drug Resistance · doi:10.1089/107662903322762743 · Cited by 112
Morita, Y., Kimura, N., Mima, T., Mizushima, T., & Tsuchiya, T. (2001) · The Journal of General and Applied Microbiology · doi:10.2323/jgam.47.27 · Cited by 111
nalD Encodes a Second Repressor of the mexAB-oprM Multidrug Efflux Operon of Pseudomonas aeruginosa
Morita, Y., Cao, L., Gould, V. C., et al. (2006) · Journal of Bacteriology · doi:10.1128/jb.01342-06 · Cited by 111
Lee, J., Lee, Y. S., Park, Y., & Kim, B. S. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.11.012 · Cited by 110
Morita, Y., Komori, Y., Mima, T., Kuroda, T., Mizushima, T., & Tsuchiya, T. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10794.x · Cited by 108
Gotoh, N., Tsujimoto, H., Tsuda, M., Okamoto, K., Nomura, A., Wada, T., Nakahashi, M., & Nishino, T. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1938 · Cited by 107
Wolter, D. J. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.05.039 · Cited by 104
Self-citationAdewoye, L. O., Sutherland, A. M., Srikumar, R., et al. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.15.4308-4312.2002 · Cited by 101
Wolter, D. J., Hanson, N. D., & Lister, P. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09639.x · Cited by 97
Self-citationEmergence of resistance to imipenem in Pseudomonas aeruginosa
Lynch, M. J., Drusano, G. L., & Mobley, H. L. T. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1892 · Cited by 94
Model System To Evaluate the Effect of ampD Mutations on AmpC-Mediated β-Lactam Resistance
Schmidtke, A. J., & Hanson, N. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01458-05 · Cited by 93
Self-citationBarnaud, G., Labia, R., Raskine, L., Pors, M.-J. S.-L., Philippon, A., & Arlet, G. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10519.x · Cited by 92
The threat from the pink corner
Livermore, D. M. (2003) · Annals of Medicine · doi:10.1080/07853890310001609 · Cited by 92
Transferable production of PER-1 β-lactamase in Pseudomonas aeruginosa
Danel, F., Hall, L. M. C., Gür, D., Akalın, H., & Livermore, D. M. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.2.281 · Cited by 91
Zhao, Q., Li, X.-Z., Srikumar, R., & Poole, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1682 · Cited by 89
Karlowsky, J. A., Kelly, L. J., Thornsberry, C., Jones, M. E., Evangelista, A. T., Critchley, I. A., & Sahm, D. F. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00466-6 · Cited by 88
Interactions of Ceftobiprole with β-Lactamases from Molecular Classes A to D
Queenan, A. M., Shang, W., Kania, M., Page, M. G. P., & Bush, K. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00218-07 · Cited by 86
nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa
Fukuda, H., Hosaka, M., Iyobe, S., Gotoh, N., Nishino, T., & Hirai, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.790 · Cited by 86
ampR Gene Mutations That Greatly Increase Class C β-Lactamase Activity in Enterobacter cloacae
Kuga, A., Okamoto, R., & Inoue, M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.561-567.2000 · Cited by 85
Mammeri, H., Nordmann, P., Berkani, A., & Eb, F. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01126.x · Cited by 83
The crystal structure of MexR from Pseudomonas aeruginosa in complex with its antirepressor ArmR
Wilke, M. S., Heller, M., Creagh, A. L., Haynes, C. A., McIntosh, L. P., Poole, K., & Strynadka, N. C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805489105 · Cited by 83
Substrate-Dependent Utilization of OprM or OpmH by the Pseudomonas aeruginosa MexJK Efflux Pump
Chuanchuen, R., Murata, T., Gotoh, N., & Schweizer, H. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2133-2136.2005 · Cited by 83
Mima, T., Sekiya, H., Mizushima, T., Kuroda, T., & Tsuchiya, T. (2005) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2005.tb03696.x · Cited by 82
Hiroshi Yoneyama, C., & Nakae, T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2385 · Cited by 80
Sevillano, E., Gallego, L., & García-Lobo, J. M. (2008) · Pathologie Biologie · doi:10.1016/j.patbio.2008.05.002 · Cited by 79
Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa
Islam, S., Jalal, S., & Wretlind, B. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00991.x · Cited by 79
Castanheira, M., Mendes, R. E., Walsh, T. R., Gales, A. C., & Jones, R. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2344-2345.2004 · Cited by 77
mvaTmutation modifies the expression of thePseudomonas aeruginosamultidrug efflux operonmexEF-oprN
Westfall, L. W., Carty, N. L., Layland, N., Kuan, P. J., Colmer‐Hamood, J. A., & Hamood, A. N. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2005.00075.x · Cited by 77
Diverse potential of beta-lactamase inhibitors to induce class I enzymes
Weber, D. A., & Sanders, C. C. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.156 · Cited by 77
Sekiya, H., Mima, T., Morita, Y., Kuroda, T., Mizushima, T., & Tsuchiya, T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2990-2992.2003 · Cited by 77
Association of Plasmid-Mediated Quinolone Resistance with Extended-Spectrum β-Lactamase VEB-1
Poirel, L., Loo, M. V. D., Mammeri, H., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.3091-3094.2005 · Cited by 77
On the Blue and Green Coloration that Appears on Bandages
Gessard, C. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_3.s775 · Cited by 74
Mammeri, H., Poirel, L., Bemer, P., Drugeon, H., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.716-720.2004 · Cited by 70
Wolter, D. J., Moland, E. S., Goering, R. V., Hanson, N. D., & Lister, P. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.05.004 · Cited by 70
Self-citationLister, P., Gardner, V. M., & Sanders, C. C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.882 · Cited by 70
Self-citationProtein Modulator of Multidrug Efflux Gene Expression inPseudomonas aeruginosa
Daigle, D. M., Cao, L., Fraud, S., Wilke, M. S., Pacey, A., Klinoski, R., Strynadka, N. C. J., Dean, C. R., & Poole, K. (2007) · Journal of Bacteriology · doi:10.1128/jb.00543-07 · Cited by 68
VEB-1-like Extended-Spectrum ß-Lactamases inPseudomonas aeruginosa, Kuwait
Poirel, L., Rotimi, V. O., Mokaddas, E. M., Karim, A., & Nordmann, P. (2001) · Emerging infectious diseases · doi:10.3201/eid0703.010322 · Cited by 67
Ochs, M. M., Lu, C., Hancock, R. E. W., & Abdelal, A. T. H. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.17.5426-5432.1999 · Cited by 61
Boutoille, D., Corvec, S., Caroff, N., Giraudeau, C., Espaze, E., Caillon, J., Plésiat, P., & Reynaud, A. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00882-6 · Cited by 60
Brown, S. D., & Traczewski, M. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki134 · Cited by 58
Two Efflux Systems Expressed Simultaneously in Multidrug-Resistant Pseudomonas aeruginosa
Pumbwe, L., & Piddock, L. J. V. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2861-2864.2000 · Cited by 58
Shiba, T., Ishiguro, K., 竹本, 法., Koibuchi, H., & Sugimoto, K. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.20.5872-5877.1995 · Cited by 53
Rhomberg, P. R., & Jones, R. N. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.07.009 · Cited by 53
Emerging epidemic of metallo-β-lactamase–mediated resistances
Jones, R. N., Biedenbach, D. J., Sader, H. S., Fritsche, T. R., Toleman, M. A., & Walsh, T. R. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.07.003 · Cited by 53
The MexA-MexB-OprM multidrug efflux system ofPseudomonas aeruginosais growth-phase regulated
Evans, K., & Poole, K. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb13481.x · Cited by 50
Emergence of IMP-4 metallo-β-lactamase in a clinical isolate from Australia
Peleg, A. Y., Franklin, C., Bell, J. M., & Spelman, D. W. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh398 · Cited by 48
Penicillin-binding proteins and induction of AmpC beta-lactamase
Sanders, C. C., Bradford, P. A., Ehrhardt, A. F., Bush, K., Young, K. D., Henderson, T. A., & Sanders, W. E. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.2013 · Cited by 47
Lister, P., & Wolter, D. J. (2005) · Clinical Infectious Diseases · doi:10.1086/426190 · Cited by 47
Self-citationRhomberg, P. R., Deshpande, L. M., Kirby, J. T., & Jones, R. N. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.05.009 · Cited by 41
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., & Nishino, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1284-1286.2001 · Cited by 38
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Pseudomonas genomes: diverse and adaptable
Silby, M. W., Winstanley, C., Godfrey, S. A. C., Levy, S. B., & Jackson, R. W. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00269.x · Cited by 960
Metadata
- Authors
- Lister, P. D., Wolter, D. J., & Hanson, N. D.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2009-10
- Volume
- 22
- Issue
- 4
- Pages
- 582-610
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2075287054
- Cited by
- 1,789
- References
- 208
- FWCI
- 19.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.